Mitochondrial double-stranded RNA fuels pancreatic cancer growth via RIG-I/TLR3 inflammation
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2528281123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Andrew T Milcarek und 17 weiteren Autor:innen. Beteiligte Einrichtung: Genome Regulation and Cell Signaling Program, The Wistar Institute, Philadelphia, PA 19104. Hauptthemen laut MEDLINE: Toll-Like Receptor 3, RNA, Double-Stranded, Pancreatic Neoplasms, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, HHS | NIH | National Cancer Institute.
Abstract (Originalsprache)
Mitochondria activate inflammation and innate immunity to protect against infections, but the role in cancer is unknown. Here, we report that patients with pancreatic ductal adenocarcinoma (PDAC) with reduced levels of the mitochondrial scaffold, Mic60, or inner mitochondrial membrane protein, exhibit increased inflammation, high NFκB activity and production of TNFα. This is mediated by double-stranded RNA (dsRNA) released from structurally defective, Mic60-low mitochondria, which engages TLR3/RIG-I sensing, activates NFκB gene expression and reprograms transcriptional and signaling networks to promote PDAC proliferation. Preclinical targeting of mitochondrial dsRNA signaling triggers rapid cell death and inhibition of tumor growth, selectively in Mic60-knockdown PDAC, without overt toxicity, in vivo. Therefore, dsRNA released from defective mitochondria generates protumorigenic inflammation and provides an actionable therapeutic target in selected PDAC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genome Regulation and Cell Signaling Program, The Wistar Institute, Philadelphia, PA 19104.
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples 80138, Italy.
- Bioinformatics Shared Resource, The Wistar Institute, Philadelphia, PA 19104.
- Proteomics Shared Resource, The Wistar Institute, Philadelphia, PA 19104.
- Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA 19104.
- Department of Pathophysiology and Transplantation, University of Milan, Milan 20122, Italy.
ORCID-Profile: Andrew T Milcarek, Prerna Kulkarni, Hsin-Yao Tang, Alessandra M Storaci, Alessandro Palleschi, Valentina Vaira, Mary V Iacocca, Nicholas J Petrelli, Michela Perego, Dario C Altieri
Förderung
- NCI NIH HHS
- HHS | NIH | National Cancer Institute
Zitieren
APA
Milcarek, A. T., Yeon, M., Esposito, C., Kulkarni, P., Kossenkov, A. V., Madzo, J., Faustino, A. M., Tang, H. Y., Storaci, A. M., Palleschi, A., Locatelli, M., Vaira, V., Iacocca, M. V., Ward, A., Sabesan, A., Petrelli, N. J., Perego, M., & Altieri, D. C. (2026). Mitochondrial double-stranded RNA fuels pancreatic cancer growth via RIG-I/TLR3 inflammation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2528281123
Vancouver
Milcarek AT, Yeon M, Esposito C, Kulkarni P, Kossenkov AV, Madzo J, et al. Mitochondrial double-stranded RNA fuels pancreatic cancer growth via RIG-I/TLR3 inflammation. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2528281123
BibTeX
@article{Milcarek2026,
author = {Milcarek, Andrew T and Yeon, Minjeong and Esposito, Camilla and Kulkarni, Prerna and Kossenkov, Andrew V and Madzo, Jozef and Faustino, Anneliese M and Tang, Hsin-Yao and Storaci, Alessandra M and Palleschi, Alessandro and Locatelli, Marco and Vaira, Valentina and Iacocca, Mary V and Ward, Andrea and Sabesan, Arvind and Petrelli, Nicholas J and Perego, Michela and Altieri, Dario C},
title = {Mitochondrial double-stranded RNA fuels pancreatic cancer growth via RIG-I/TLR3 inflammation},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2528281123}
}
EUVIMED